Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cenetron Announces Launch of ARCHIVA BioLogistics

Published: Sunday, September 15, 2013
Last Updated: Sunday, September 15, 2013
Bookmark and Share
New Company to Specialize in Clinical Kit Manufacturing, Sample Logistics, and Sample Storage

Archiva Biologistics will focus on the design and manufacture of clinical collection kits, innovative laboratory requisition documents, sample logistics, and sample storage. All facets of Archiva are operationally linked and managed with GlobeSyncTM, an enterprise-wide 21-CFR-part 11 compliant Laboratory Information Management System, and Manufacturing software platform. GlobeSync is a proprietary software system and data portal developed at Cenetron Diagnostics.

Archiva will be housed in a recently completed 42,000 sq. foot facility, with state-of-the art manufacturing and sample storage capabilities.

Archiva customers are able to utilize individual services, such as kit building or sample storage, or can take advantage of a full complement of services from protocol review, kit design, sample logistics, sample storage, and testing.

New customers to Archiva include pharma and biotech companies, national reference laboratories, in-vitro diagnostic companies, and academic institutions.

Dwight DuBois, CEO, commented, “Archiva BioLogistics has been in development for several years. We recognized that high quality, cost containment, and maximum efficiency of clinical trial and reference laboratory work starts with flawless sample collection, transportation, and storage practices. We have come up with innovative, user-friendly answers to this common problem, based largely on feedback from customers with unmet needs.”

Vice President of Operations Brandon Harper commented, “By utilizing proven processes and best practices developed at Cenetron, Archiva is able to provide a complete sample management solution for a project of any size and for any location worldwide. Many of Archiva’s new clients are from outside our traditional pharma client base, and include diagnostic companies, specialty laboratories, and academic institutions.”

Cenetron Diagnostics is a premier provider of molecular laboratory services, providing support for anti-viral and oncology drug development programs, and pharmacogenomics. Founded in 1995, Cenetron has supported pivotal global trials in North and South America, Europe, Africa and the Pacific Rim. Cenetron's client list includes leading pharmaceutical clients in the United States and Europe.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!